Functional studies have found that the activation of ACE2/Ang-(1–7)/MasR axis can inhibit proliferation, angiogenesis, invasion and metastasis of cancer cells, thereby counteracting the biological effects of the ACE/Ang II system [19, 22, 23]. Here, ACE2 is linked to cancer.